These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7908776)

  • 1. Managing patients with myocardial infarction after hospital discharge.
    Havranek EP
    Am Fam Physician; 1994 Apr; 49(5):1109-19, 1123-4. PubMed ID: 7908776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After your heart attack.
    Harv Mens Health Watch; 1998 Oct; 3(3):1-5. PubMed ID: 9766175
    [No Abstract]   [Full Text] [Related]  

  • 5. Management after a first myocardial infarction.
    Flapan AD
    Hosp Pract (1995); 1996 May; 31(5):133-7, 141-6. PubMed ID: 8632043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management after myocardial infarction: an evidence-based perspective.
    Sharpe N
    Br J Clin Pract Suppl; 1996 Jul; 84():25-30. PubMed ID: 8994999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H; Searles G; Gillis A
    Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors in acute myocardial infarction.
    Murdoch DR; McMurray JJ
    Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [After-care of the patient with myocardial infarct].
    Muntwyler J; Rickli H; Kiowski W; Amann FW
    Praxis (Bern 1994); 1997 Sep; 86(38):1467-70. PubMed ID: 9381048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postmyocardial infarction in the elderly patient.
    Forman R; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
    J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory management of patients after myocardial infarction].
    Bloch A
    Rev Med Suisse Romande; 2000 Feb; 120(2):159-66. PubMed ID: 10748703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing and managing asymptomatic left ventricular dysfunction after myocardial infarction.
    Albert NM; Lewis C
    Crit Care Nurse; 2008 Apr; 28(2):20-37; quiz 38. PubMed ID: 18378726
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing, causes, and predictors of death after three years' follow-up in the Danish Multicenter Randomized Study of Fibrinolysis versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trial.
    Busk M; Maeng M; Kristensen SD; Thuesen L; Krusell LR; Mortensen LS; Steinmetz ER; Nielsen TT; Andersen HR;
    Am J Cardiol; 2009 Jul; 104(2):210-5. PubMed ID: 19576349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.